Methyl 6-amino-1H-indazole-7-carboxylate finds its primary application in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of various biologically active compounds, particularly those targeting specific enzymes or receptors in medicinal chemistry. Researchers utilize this compound to develop potential drug candidates for treating diseases such as cancer, inflammation, and neurological disorders. Its indazole core structure is often incorporated into molecules designed for kinase inhibition, making it valuable in the creation of targeted therapies. Additionally, its functional groups allow for further chemical modifications, enabling the exploration of diverse pharmacological properties. This compound is also employed in the study of structure-activity relationships (SAR) to optimize the efficacy and selectivity of new therapeutic agents.